Conversion to rapamycin in liver transpant recipients with renal insufficiency / 南方医科大学学报
Journal of Southern Medical University
;
(12): 2276-2278, 2009.
Artigo
em Chinês
| WPRIM
| ID: wpr-325127
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the efficacy of conversion from calcineurin-inhibitor (CNI) to rapamycin in liver recipients with CNI-associated renal insufficiency.</p><p><b>METHODS</b>This retrospective study examined the liver transplant recipients who had switched from CNI to rapamycin between January 2004 and June 2008 in the first affiliated hospital of Sun Yat-sen University. The data of renal function before and after the conversion were analyzed by Wilcoxon sum rank test, and rapamycin-related adverse effects were also observed.</p><p><b>RESULTS</b>Compared with that before conversion, the renal funtion 4 months after the conversion improved significantly (P<0.05). The blood lipid level 3 months after the conversion increased significantly (P<0.05) but were well controlled.</p><p><b>CONCLUSION</b>Rapamycin can be used safely as a good alternative in liver transplant recipients with CNI-related renal insufficiency.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Estudos Retrospectivos
/
Transplante de Fígado
/
Sirolimo
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Insuficiência Renal
/
Inibidores de Calcineurina
/
Imunossupressores
Tipo de estudo:
Estudo observacional
Limite:
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Journal of Southern Medical University
Ano de publicação:
2009
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS